4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001179110-20-004009
Options or other derivatives
- Chief Commercial Officer acquired 70,517 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Marek David C Chief Commercial Officer | 2020-03-17 | Grant or award · Employee Stock Option (Right to Buy) | +53,984 | 53,984 | D | ||
| Marek David C Chief Commercial Officer | 2020-03-17 | Grant or award · Restricted Stock Units | +16,533 | 16,533 | D | ||
Loading xslF345X03/edgar.xml…